Initially, the CAD risk associated with 9p21.3 genetic variants and ANRIL expression was reported being independent of traditional CAD risk factors like sex, smoking, obesity, hypertension, or diabetes [15,16,17]. The gene discussed is CDKN2B-AS1; the disease is obesity due to melanocortin 4 receptor deficiency.